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Abstract: The mesoporous silica nanoparticles (MSN) in different pore size and sirolimus (SRL) loaded 
self-microemulsifying drug delivery system (SMEDDS) were prepared.  The results in morphology were          
collected by scanning electron microscope, transmission electron microscope, small-angle X-ray diffraction,       
and N2 adsorption-desorption.  The results showed that the prepared MSN has ordered nanochannels with a      
pore size of 6.3, 8.1, 10.8 nm, respectively.  The particle size of SRL-SMEDDS were measured by particle       
sizing system, which was 20.6 ± 1.3 nm.  The stirring method was developed to prepare SRL-SMEDDS-MSN.  
It was found that the optimal ratio of SRL-SMEDDS to MSN was 2?1, while the drug loading rate was near 
0.83%, and the flow properties of SRL-SMEDDS-MSN were of good condition.  The differential scanning      
calorimetry results proving a molecular or amorphous dispersed state of SRL in MSN while the suspension        
experiment has shown great reconstitution properties of SRL-SMEDDS-MSN.  There is no significant influence 
on maximum drug release rate of different pore size of SRL-SMEDDS-MSN in 250 mL water within 2 h, while 
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the results of the first 40 min have an obvious difference.  Above all, MSN might provide a new strategy for      
the solidification of SMEDDS. 
Key words: sirolimus; mesoporous silica nanoparticle; self-microemulsifying drug delivery system;       
solidification; nano-carrier; in vitro dissolution rate 
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Figure 1  Preparation of different pore size of mesoporous silica 
nanoparticles (SBA-15).  A: SBA-15 (6.3); B: SBA-15 (8.1); C: 
SBA-15 (10.8) 
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Figure 3  The ultraviolet spectrum of SRL 
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Figure 4  High performance liquid chromatogram of SRL.  A: 
Blank; B: Standard; C: Sample; 1: SRL; 2: SRL isomer 
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Table 1  The particle sizing distribution and polydispersity     
index (PDI) of SMEDDS and SRL-SMEDDS.  n = 3, x ± s 
Sample Particle size/nm PDI 
SMEDDS 21.4 ± 1.8 0.173 ± 0.02 
SRL-SMEDDS 20.6 ± 1.3 0.042 ± 0.05 
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Figure 2  Mechanism of the preparation and release of SRL-SMEDDS-SBA-15.  SRL: Sirolimus; SMEDDS: Self-microemulsifying 
drug delivery system 




Figure 5  Scanning electron microscope (SEM) of SBA-15 (6.3) 
(A), SBA-15 (8.1) (B), SBA-15 (10.8) (C) and transmission     
electron microscope (TEM) of SBA-15 (6.3) (D), SBA-15 (8.1) 
(E), SBA-15 (10.8) (F) 
 
Figure 6  Small angle X-ray diffraction (SAXD) of SBA-15 
(6.3) (A), SBA-15 (8.1) (B), SBA-15 (10.8) (C) 
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?????, ??????? 40°, ????? 20%, 
?????? 1.25, ?? SRL-SMEDDS-SBA-15 ?
???????????????? 2?1, ????
??? 
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? 190 ?? 210 ?????????, ?????    
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Figure 7  N2 Adsorption-desorption isotherm and pore size distribution of SBA-15 (6.3) (A), SBA-15 (8.1) (B), SBA-15 (10.8) (C) 
 
Table 2  Drug loading rate of SRL-SMEDDS-SBA-15 with different ratio of SRL-SMEDDS to SBA-15.  n = 3, x ± s 
M (SRL-SMEDDS)?m (SBA-15) 
 Drug loading rate/%  
SRL-SMEDDS-SBA-15 (6.3) SRL-SMEDDS-SBA-15 (8.1) SRL-SMEDDS-SBA-15 (10.8) 
1?1 0.62 ± 0.15 0.60 ± 0.17 0.58 ± 0.16 
2?1 0.83 ± 0.08 0.84 ± 0.06 0.83 ± 0.06 
3?1 0.93 ± 0.09 0.94 ± 0.10 0.93 ± 0.12 
 
Table 3  Flow properties of SRL-SMEDDS-SBA-15 (6.3), SRL-SMEDDS-SBA-15 (8.1), SRL-SMEDDS-SBA-15 (10.8)  
Sample Ratio Angle of repose/° Compressibility index/% Hausner ratio 
m (SRL-SMEDDS)?m (SBA-15) (6.3)  0 30.17 14.19 1.17 
 1?1 30.35 14.54 1.17 
 2?1 31.89 14.93 1.18 
 3?1 − − − 
m (SRL-SMEDDS)?m (SBA-15) (8.1)  0 29.82 14.04 1.16 
 1?1 30.27 14.52 1.17 
 2?1 30.88 15.07 1.17 
 3?1 − − − 
m (SRL-SMEDDS)?m (SBA-15) (10.8)  0 29.09 13.24 1.16 
 1?1 29.35 13.75 1.16 
 2?1 30.98 14.18 1.17 
 3?1 − − − 
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Figure 8  DSC of SRL-SMEDDS-SBA-15.  a: SRL; b1, b2, b3: 
SBA-15 (6.3), SBA-15 (8.1), SBA-15 (10.8); c1, c2, c3: physical 
mixture of SRL and SBA-15 (6.3), physical mixture of SRL and 
SBA-15 (8.1), physical mixture of SRL and SBA-15 (10.8); d1, 
d2, d3: SRL-SMEDDS-SBA-15 (6.3), SRL-SMEDDS-SBA-15 
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Table 4  Particle sizing distribution of SRL-SMEDDS-SBA-15.  
n = 3, x ± s 
Sample Particle size/nm 
SRL-SMEDDS 20.6 ± 1.3 
SRL-SMEDDS-SBA-15 (6.3) 20.9 ± 1.8 
SRL-SMEDDS-SBA-15 (8.1) 20.7 ± 1.5 
SRL-SMEDDS-SBA-15 (10.8) 20.5 ± 1.6 
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(10.8) ????????????, ??????
?????????, ?? 1 h?????????
???????, ???????????? 9? 
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?????????????, ??? SRL???? 
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